Subconjunctival application of plasma platelet concentrate in the treatment of ocular burns. Preliminary results;Aplicación subconjuntival de concentrado de plaquetas plasmáticas en el tratamiento de quemaduras oculares. Resultados preliminares

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 82, Issue 8, 2007, Pages 475-481

  Márquez De Aracena Del Cid, Rafael ^a,c,d   Montero De Espinosa, I ^a,d   Munoz M ^b,d   Pereira, G ^b,d  

^a UNIVERSITY OF SEVILLE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c Hospital FREMAP de Sevilla   (Spain)

^d UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Cornea; Growth factors; Ocular burns; Ocular surface; Platelet

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT;

ARTICLE; COMPARATIVE STUDY; EVALUATION; EYE BURN; FOLLOW UP; HUMAN; INJECTION; OCCUPATIONAL ACCIDENT; OINTMENT; STATISTICAL ANALYSIS; THROMBOCYTE RICH PLASMA; TIME; TREATMENT OUTCOME; WOUND HEALING;

ACCIDENTS, OCCUPATIONAL; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; DATA INTERPRETATION, STATISTICAL; EYE BURNS; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; OINTMENTS; PLATELET-RICH PLASMA; TIME FACTORS; TREATMENT OUTCOME; WOUND HEALING;

EID: 38449086255     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Reim M, Redbrake C, Schrage N. Heridas oculares químicas y térmicas. Tratamiento quirúrgico y médico basado en hallazgos clínicos y patofisiológicos. Arch Soc Esp Oftalmol 2001; 76; 79-124.
2. Morgan SJ. Chemical burns of the eye: causes and management. Br J Ophthalmol 1987; 71: 854-857.
3. Rapuano CJ, Luchs J, Kim T. Requisitos en Oftalmología. Segmento Anterior. Madrid: Harcourt 2001; 288-293.
4. Cameron JD. Corneal reaction to injury. In Krachmer JH, Mannis MJ, Holland EJ. Cornea: Fundamentals of cornea and external diseases. St. Louis: Mosby; 1997.
5. Kruse FE, Tseng SC. Epithelial growth is promoted by a mitogen from fibroblast conditioned medium. Invest Ophthalmol Vis Sci (ARVO Suppl) 1991; 34: 1011.
6. Harris TM, Berry ER, Pakurar AS, Sheppard LB. Biochemical transformation of bulbar conjunctiva into corneal epithelium: an electrophoretic analisys. Exp Eye Res 1985; 41: 597-605.
7. Buck RC. Ultrastructure of conjunctival epithelium replacing corneal epithelium. Curr Eye Res 1986; 5: 149-159.
8. Huang AJ, Watson BD, Hernandez E, Tseng SC. Induction of conjunctival transdifferentiation by photothrombotic occlusion of corneal neovascularization. Ophthalmology 1988; 95: 228-235.
9. Pfister RR, Haddox JL, Dodson RW, Harkins LE. Alkali-burned collagen produces a locomotory and metabolic stimulant neutrophils. Invest Opthalmol Vis Sci 1987; 28: 295-304.
10. Ralph RA. Tetracyclines and the treatment of corneal stromal ulceration: a review. Cornea 2000; 19: 274-282.
11. Pfister RR, Paterson CA, Spiers JW, Hayes SA. The efficacy of ascorbate treatment after severe experimental alkali burns depends upon the route of administration. Invest Ophthalmol Vis Sci 1980; 19: 1526-1529.
12. Kruse FE, Rohrschneider K, Völcker HE. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology 1999; 106: 1504-1510.
13. Morgan S, Murray A. Limbal autotransplantation in the acute and chronic phases of severe chemical injures. Eye 1996; 10: 349-354.
14. Trusov MS, Rozenkrants KB. Surgical treatment of chemical burns of the eye in combination with irrigation with defibrinated blood and subconjunctival administration of autoblood with antibiotics. Vestn Oftalmol 1966; 79: 61-65.
15. Sallai S, Fehér J, Podhorányi G. Experience with autologous blood therapy in burns. Klin Monatsbl Augenheilkd 1967; 150: 879-886.
16. Dolezalova V. Kutskova L. Subconjunctival injection of autogenous blood in the eye after thermical and chemical burns. Cesk Oftalmol 1973; 29: 207-212.
17. Lenkiewicz E, Ferencowa A, Szewczykowa E. Subconjuctival autohemotherapy of eye burns in our cases. Klin Oczna 1992; 94: 113-114.
18. Kuprianowicz W, Czesnel H. Results of treatment of calcium eye burns with subconjunctival injections of blood. Klin Oczna 1969; 39: 51-54.
19. Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984; 27: 459-461.
20. Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999; 106: 1984-1989.
21. Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, et al. Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol 1999; 83: 390-395.
22. Goto E, Shimmura S, Shimazaki J, Tsubota K. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 2001; 20: 807-810.
23. Bennet NT, Schultz GS. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg 1993; 165: 728-737.
24. Rendu F, Brohard-Bohn B. The platelet release reaction: granuleś constituents, secretion and functions. Platelets 2001; 12: 261-273.
25. Gebhardt M, Mentlein R, Schaudig U, Pufe T, Recker K, Nölle B, et al. Differential expression of vascular endotehial growth factor implies the limbal origin of pterygia. Ophthalmology 2005; 112: 1023-1030.
26. Hartwig D, Harloff S, Liu L, Schlenke P, Wedel T, Geerling G. Epitheliotrophic capacity of a growth factor preparation produced form platelet concentrates on corneal epithelial cells: a potencial agent fort the treatment of ocular surface defects? Transfusion 2004; 44: 1724-1731.
27. Hartwig D, Herminghaus P, Wedel T, Liu L, Schlenke P, Dibbelt L, et al. Topycal treatment of ocular surface defects: comparison of epitheliotrophic capacity of fresh frozen plasma and serum on corneal epithelial cells in an in vitro cell culture model. Tranfus Med 2005; 15: 107-113.
28. Marquez de Aracena del Cid R, Montero de Espinosa Escoriaza I, Muñoz Sáez M, Pereira Gutiérrez G, Martín Leal F. Tratamiento con concentrado plaquetario plasmático subconjuntival y tópico en el trasplante de limbo. Mapfre Medicina 2006; 17: 280-285.
29. Dua HS, King AJ, Joseph A. A new classification of ocular surface burns. Br J Ophthalmol 2001; 85: 1379-1383.
30. Matsumoto Y, Dogru M, Goto E, Ohashi Y, Kojima T, Ishida R, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004; 111: 1115-1120.
31. Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanabe R, et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Trasnplant 2003; 31: 579-583.
32. Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984; 27: 459-461.
33. Tananuvant N, Daniell M, Sullivan LJ, Yi Q, Mckelvie P, McCarty DJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea 2001; 20: 802-806.
34. Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999; 106: 1984-1989.
35. Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, et al. Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol 1999; 83: 390-395.
36. Lambiase A, Manni L, Rama P, Bonini S. Clinical application of nerve growth factor on human corneal ulcer. Arch Ital Biol 2003; 141: 141-148.
37. Baum J. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. Surv Ophthalmol 1999; 43: 372-373.
38. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 1998; 338: 1174-1180.
39. Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 2000; 107: 1347-1351.
40. Liu L, Li YP, Huang SQ, Lin JX, Zhang WX. Mechanism of keratinocyte growth factor-2 accelerating corneal epithelial wound healing on rabbit alkali burned cornea. Zhonghua Yan Ke Za Zhi 2005; 41: 364-368.
41. Mathers WD, Sherman M, Fryczkowski A, Jester JV. Dose-dependent effects of epidermal growth factor on corneal wound healing. Invest Ophthalmol Vis Sci 1989; 30: 2403-2406.
42. Yam HF, Pang CP, Fan DS, Fan BJ, Yu EY, Lam DS. Growth factor changes in ex vivo expansion of human limbal epithelial cells on human amniotic membrane. Cornea 2002; 21: 101-105.
43. Daniele S, Gilbard JP, Schepens CL. Treatment of persistent epithelial defects in neurotrophic keratitis with epidermal growth factor: a preliminary open study. Graefes Arch Clin Exp Ophthalmol 1992; 230: 314-317.